financetom
Business
financetom
/
Business
/
Market Chatter: Alpine Immune Sciences Considering Potential Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Alpine Immune Sciences Considering Potential Sale
Apr 10, 2024 10:11 AM

12:45 PM EDT, 04/10/2024 (MT Newswires) -- Alpine Immune Sciences ( ALPN ) is weighing multiple options, including a potential sale, after attracting takeover interest, Bloomberg reported, citing people with knowledge of the matter.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 42.14, Change: +3.20, Percent Change: +8.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Graham Holdings' Q4 Adjusted Net Income, Revenue Rise
Graham Holdings' Q4 Adjusted Net Income, Revenue Rise
Feb 26, 2025
08:48 AM EST, 02/26/2025 (MT Newswires) -- Graham Holdings ( GHC ) reported Q4 adjusted net income Wednesday of $22.58 per diluted share, up from $10.94 a year earlier. FactSet estimates were not available. Revenue for the quarter ended Dec. 31 was $1.25 billion, up from $1.17 billion a year earlier. An analyst surveyed by FactSet expected $1.27 billion. ...
Regeneron Says US FDA Accepts for Review Resubmission of Application for Follicular Lymphoma Drug
Regeneron Says US FDA Accepts for Review Resubmission of Application for Follicular Lymphoma Drug
Feb 26, 2025
08:48 AM EST, 02/26/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday that the US Food and Drug Administration has accepted for review the resubmission of its biologics license application for odronextamab drug, a treatment for relapsed/refractory follicular lymphoma after two or more lines of systemic therapy. The target action date for the agency's decision is July 30,...
High Liner Foods Q4 Adjusted Profit Surges
High Liner Foods Q4 Adjusted Profit Surges
Feb 26, 2025
08:45 AM EST, 02/26/2025 (MT Newswires) -- High Liner Foods ( HLNFF ) , a frozen seafood company, on Wednesday said fourth-quarter adjusted profit surged 71%. Adjusted profit advances to US$12.5 million, or US$0.41 per share, from US$7.3 million, or US$0.23 per share, in the prior-year period. Sales dipped to $235 million from $237 million. Lower pricing, product mix and...
Europe plans to ease sustainability reporting rules to compete globally
Europe plans to ease sustainability reporting rules to compete globally
Feb 26, 2025
* Commission proposes mobilising 100 billion euros for clean tech * Wants to simplify state aid rules * Proposals come as Trump administration rolls back red tape * Reforms need support in European Parliament, among EU states (Recasts with plans to loosen rules on sustainability, writes through) By Kate Abnett and Julia Payne BRUSSELS, Feb 26 (Reuters) - The European...
Copyright 2023-2026 - www.financetom.com All Rights Reserved